Corante

About this author
Zack Lynch is author of The Neuro Revolution: How Brain Science Is Changing Our World (St. Martin's Press, July 2009).
He is the founder and executive director of the Neurotechnology Industry Organization (NIO) and co-founder of NeuroInsights. He serves on the advisory boards of the McGovern Institute for Brain Research at MIT, the Center for Neuroeconomic Studies, Science Progress, and SocialText, a social software company. Please send newsworthy items or feedback - to Zack Lynch.
Follow me on Twitter at @neurorev
Receive by email

GUEST AUTHOR ARCHIVES
THE NEURO REVOLUTION
TNRCoverWeb120.jpg Buy on Amazon
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

Brain Waves

« Recent NeuroInsights and Neurotech Press | Main | Two Companies To Begin Offering "Lie Detection" Using fMRI »

June 19, 2006

Stockholm / Uppsala Neurotechnology Cluster Analyzed

Email This Entry

Posted by Zack Lynch

Last week I received a superb 40-page report analyzing the factors that have been important in establishing the the Stockholm/Uppsala regions' position in the global neurotechnology industry. Written by Swedish neuroscience graduate students Jesper Ericsson, Mikael Nygård and Minrui Zheng, the report was a response to NeuroInsights' Neurotech Nexus Report that analyzed the leading regional neurotech clusters worldwide and which ranked this particular region a competitive 10th place. Here is a snippet from the report Stockholm/Uppsala - Strengthening and Enhancing Its Position as an Emerging Neurotechnology Cluster:

"Swedish neuroscience is characterized by excellence in research, and this is the very foundation of the neurotechnology industry. The Stockholm/Uppsala cluster is the strongest region in Sweden and several outstanding research groups have been identified in basic, clinical and applied neuroscience at especially three main universities: Karolinska Institutet, the Royal Institute of Technology, and Uppsala University. There was a general agreement throughout the interviews that the ranking by NeuroInsights in 2005 that listed Stockholm/Uppsala as the 10th strongest neurotechnology cluster in the world was a good and fair judgment, and some even advocated that the cluster was stronger and should be ranked higher.

swedish_brain_w100.jpgIn addition to academic research, the ranking was also based on the regions access to venture capital as well as the number neurotechnology companies. The venture capital business in Sweden appears to be strong, especially in comparison to other EU countries, and there are several life science specialized firms within the region with HealthCap as the largest actor. There is also an increased activity by foreign venture capital firms that wants to access the Swedish life science sector and invest at early stage in start-ups (Interviews with Ylva Williams and Kai Hammerich, ISA)...

There is however also several worrying signs within the region that are mainly concerned with the inadequate measures taken by the government to increase the growth rate of the neurotechnology sector and the region in general. Within academia, there is a growing and alarming concern about the halting funding of research together with growing costs in terms of rent and administration.

The recognition of neuroscience in general as the potentially strongest area within the lifescience sector in Sweden by the Invest in Sweden Agency and others in 2001, was an important recognition of the excellence of Swedish neuroscience and later led to the establishment of Swedish Brain Power. The placement of the OECD neuroinformatics international coordinating facility in Stockholm is another important international recognition of the region. If these and other efforts such as the “Norra Station” project by Stockholm BioScience are successful they will surely contribute to the excellence of this neurotechnology cluster, which will hopefully maintain and also enhance its international competitiveness.

Our report shows that with adequate and focused measures, the Stockholm/Uppsala neurotechnology cluster has the ability not only to sustain its strong position, but to grow considerably in volume, strength and excellence."

Comments (3) + TrackBacks (0) | Category: Neurotech Industry


COMMENTS

1. Alvaro on June 23, 2006 7:43 PM writes...

Very timely report and blog entry. We have seen world-class research and applications from Karolinska in the fields of ageing and computer-based working memory training for people with ADD/ ADHD, like Dr. Klingberg's Robomemo, reviewed in Scientific American http://scientificamerican.com/article.cfm?chanID=sa004&articleID=000560D5-7252-12B9-9A2C83414B7F0000

Permalink to Comment

2. dave alden on June 24, 2006 2:45 PM writes...

Another interesting Stockholm based company is Neuronova, that recently received and FDA approval for stem cell based treatments.

Is the Swedish report available or published somewhere?

Permalink to Comment

3. Kensai on June 27, 2006 9:12 AM writes...

The Swedish example is excellent! More EU countries should follow it if we want to see a 'critical mass' of companies working on [Applied] Neuroscience this side of the pond.

Constantine

Permalink to Comment


EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
Chinese Cover of The Neuro Revolution
The Neuro Revolution Lands In China
How Neuroscience Will Change the World - My Interview on Reason.tv
Neuroscience Hearing on Capitol Hill Wednesday Sept 29, 2pm
The Neuro Revolution Published in Japan as "Neuro Wars"
Neurotech 2010: Translational Researchers Highlight Innovation
The Neuro Revolution in China Progressing
Speakers for Neurotech 2010 - Boston, May 19-20